title: Selective iGluR5 receptor antagonists

abstract: 
The present invention provides a method of treating or preventing migraine comprising administering to a patient in need thereof an effective amount of a selective iGluRreceptor antagonist. The present invention further provides novel compounds functional as selective iGluRreceptor antagonists as well as compositions and formulations comprising said selective iGluRreceptor antagonists.